GPR39 Neurons
Introduction
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">GPR39 Neurons</th>
</tr>
<tr>
<td class="label">Name</td>
<td><strong>GPR39 Neurons</strong></td>
</tr>
<tr>
<td class="label">Type</td>
<td>Cell Type</td>
</tr>
</table>
Gpr39 Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
GPR39 neurons express the G protein-coupled receptor 39 (GPR39), a unique zinc-sensing GPCR that responds to extracellular zinc ions (Zn²⁺). GPR39 is widely expressed throughout the brain, particularly in regions involved in learning, memory, and mood regulation. This receptor represents a critical link between zinc homeostasis and neuronal function, making it an important therapeutic target for neurodegenerative and neuropsychiatric disorders. [@barragniglesias2018]
Molecular Biology
The GPR39 Gene
The
GPR39 gene (G Protein-Coupled Receptor 39) is located on chromosome 9q22.1 and encodes a GPCR belonging to the ghrelin receptor family (MT3). Key features: [@stern2019]
- Gene ID: 2864
- Protein length: 435 amino acids
- Molecular weight: ~47 kDa
- G protein coupling: Gq, Gs - activates PLCβ and stimulates cAMP
...GPR39 Neurons
Introduction
<table class="infobox infobox-cell">
<tr>
<th class="infobox-header" colspan="2">GPR39 Neurons</th>
</tr>
<tr>
<td class="label">Name</td>
<td><strong>GPR39 Neurons</strong></td>
</tr>
<tr>
<td class="label">Type</td>
<td>Cell Type</td>
</tr>
</table>
Gpr39 Neurons is an important cell type in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
GPR39 neurons express the G protein-coupled receptor 39 (GPR39), a unique zinc-sensing GPCR that responds to extracellular zinc ions (Zn²⁺). GPR39 is widely expressed throughout the brain, particularly in regions involved in learning, memory, and mood regulation. This receptor represents a critical link between zinc homeostasis and neuronal function, making it an important therapeutic target for neurodegenerative and neuropsychiatric disorders. [@barragniglesias2018]
Molecular Biology
The GPR39 Gene
The
GPR39 gene (G Protein-Coupled Receptor 39) is located on chromosome 9q22.1 and encodes a GPCR belonging to the ghrelin receptor family (MT3). Key features: [@stern2019]
- Gene ID: 2864
- Protein length: 435 amino acids
- Molecular weight: ~47 kDa
- G protein coupling: Gq, Gs - activates PLCβ and stimulates cAMP
Receptor Structure
GPR39 possesses the characteristic seven-transmembrane domain structure: [@huang2008]
- N-terminal extracellular domain - zinc binding site
- Seven transmembrane helices - signal transduction
- Third intracellular loop - G protein coupling specificity
- C-terminal tail - phosphorylation and desensitization sites
Zinc Sensing Mechanism
GPR39 is unique among GPCRs in its ability to sense zinc: [@frederickson2005]
- Zinc binding sites in the extracellular domain
- Zn²⁺ concentrations: Activation at micromolar concentrations
- Allosteric modulation - zinc acts as positive allosteric modulator
- Constitutive activity - receptor shows basal activity without ligand
Anatomy and Distribution
Brain Regions
GPR39 is expressed in multiple brain regions: [@sensi2009]
Hippocampus
- CA1-CA3 pyramidal neurons
- Dentate gyrus granule cells
- Hilus/Polymorphic layer
- Highest expression in hippocampus
Cortex
- Layer 2/3 pyramidal neurons
- Layer 5 pyramidal neurons
- Cortical interneurons
Hypothalamus
- Arcuate nucleus (ARC)
- Paraventricular nucleus (PVN)
- Supraoptic nucleus (SON)
- Preoptic area
Other Regions
- Amygdala - emotional processing
- Olfactory bulb - odor processing
- Brainstem - autonomic centers
- Spinal cord - sensory transmission
Cellular Expression
GPR39 is expressed in: [@bitanihirwe2009]
- Principal neurons (pyramidal, granule cells)
- Interneurons (various subtypes)
- Astrocytes - glial zinc signaling
- Microglia - neuroinflammation modulation
Electrophysiology
GPR39 neurons exhibit zinc-modulated electrical activity: [@mlyniec2012]
Resting Properties
- Resting membrane potential: -65 to -75 mV
- Input resistance: 150-350 MΩ
- Membrane time constant: 10-20 ms
Zinc Effects
- Depolarization - Zn²⁺ activates GPR39, leading to depolarization
- Increased firing rate - GPR39 activation enhances neuronal excitability
- Modulation of NMDA receptors - Zn²⁺ inhibits NMDA receptors
- GABAergic modulation - zinc affects GABA release
Synaptic Properties
- Excitatory synaptic transmission: Enhanced by GPR39 activation
- Inhibitory synaptic transmission: Zinc modulates GABA release
- Plasticity: GPR39 regulates LTPmechanisms/long-term-potentiation) and LTD
Function
Zinc Homeostasis
GPR39 is central to brain zinc metabolism:
- Extracellular Zn²⁺ detection - monitors synaptic zinc
- Zinc trafficking - regulates zinc movement across membranes
- Intracellular signaling - Zn²⁺ as second messenger
- Synaptic zinc release - activity-dependent release from presynaptic terminals
Synaptic Plasticity
GPR39 modulates learning and memory:
- Long-term potentiation (LTP) - zinc enhances LTP via GPR39
- Long-term depression (LTD) - regulates depotentiation
- Synaptic strengthening - AMPA receptor trafficking
- Dendritic spine morphology - affects spine density and size
Neuroprotection
Zinc signaling through GPR39 provides neuroprotective effects:
- Oxidative stress reduction - antioxidant enzyme regulation
- Apoptosis inhibition - anti-apoptotic signaling
- Mitochondrial function - bioenergetic protection
- Neuroinflammation modulation - glial activation regulation
Mood and Behavior
GPR39 is implicated in emotional regulation:
- Anxiety-related behaviors - GPR39 knockout mice show anxiety
- Depression-like behaviors - zinc has antidepressant effects
- Fear conditioning - zinc-dependent learning
- Social behavior - social interaction deficits in GPR39-/-
Signaling Pathways
GPR39 activates multiple intracellular cascades:
Gq-PLC Pathway
- Phospholipase C (PLC) activation
- IP3 production - calcium release from ER
- DAG formation - PKC activation
- Calcium signaling - neuronal excitation
Gs-cAMP Pathway
- Adenylate cyclase activation
- cAMP production
- PKA activation
- CREB phosphorylation - gene transcription
MAPK/ERK Pathway
- ERK1/2 activation
- Cell growth and differentiation
- Synaptic plasticity - LTP regulation
- Neuroprotection - survival signaling
Disease Relevance
Alzheimer's Disease (AD)
GPR39 is critically involved in AD pathogenesis:
- Zinc dyshomeostasis - altered Zn²⁺ in AD brains
- Amyloid-β interaction - Zn²⁺ promotes Aβ aggregation
- Tau pathology - zinc affects tau phosphorylation
- Synaptic dysfunction - GPR39 signaling impairment
- Therapeutic potential - GPR39 agonists under investigation
Parkinson's Disease (PD)
Zinc and GPR39 are implicated in PD:
- Nigral zinc accumulation - elevated Zn²⁺ in SNc
- Dopaminergic neuron vulnerability - zinc neurotoxicity
- α-Synuclein aggregation - zinc interaction with α-syn
- Mitochondrial dysfunction - oxidative stress
Depression and Anxiety
GPR39 mediates zinc's neuropsychiatric effects:
- Antidepressant action - zinc has rapid antidepressant effects
- Anxiolytic properties - reduces anxiety-like behavior
- GPR39 knockout phenotype - depression/anxiety behaviors
- Synaptic plasticity deficits - emotional circuit dysfunction
Epilepsy
Zinc homeostasis through GPR39 affects seizure susceptibility:
- Zn²⁺ in epileptogenesis - altered zinc in seizures
- GPR39 alterations - changed expression in epilepsy
- Therapeutic targeting - GPR39 modulators for seizures
Other Conditions
- Stroke - zinc-mediated neuroprotection
- Traumatic brain injury (TBI) - GPR39 in recovery
- Autism spectrum disorder (ASD) - zinc dysregulation
- Schizophrenia - GPR39 genetic associations
Therapeutic Implications
Drug Development
Targeting GPR39 offers therapeutic opportunities:
- GPR39 agonists - neuroprotection, antidepressant effects
- GPR39 antagonists - may reduce zinc toxicity
- Zinc-based therapies - Zn²⁺ supplementation
- Allosteric modulators - subtype-selective compounds
Clinical Applications
- Alzheimer's disease - GPR39-targeted neuroprotection
- Depression - zinc/GPR39 antidepressant strategies
- Parkinson's disease - dopaminergic neuroprotection
- Epilepsy - seizure control via GPR39
Research Methods
Experimental Models
- GPR39 knockout mice - behavioral and biochemical studies
- Zinc-deficient diets - manipulate brain zinc
- Primary neuron cultures - in vitro GPR39 studies
- Brain organoids - human GPR39 modeling
Molecular Techniques
- qPCR - GPR39 mRNA expression
- Western blot - protein levels
- Immunohistochemistry - cellular localization
- Radioligand binding - receptor density
- Fluorescent zinc sensors - real-time Zn²⁺ imaging
- GPR39 Gene - GPR39 gene page
- G Protein-Coupled Receptors - GPCR pathways
- Hippocampal Neurons - Hippocampal cell types
- [Alzheimer's Disease](/diseases/alzheimers-disease) AD disease page
- Zinc Signaling - Zinc signaling pathways
External Links
- [IUPHAR Database: GPR39](https://www.guidetopharmacology.org/GRAC/receptorDisplayForward?receptorId=229)
- [UniProt: GPR39 (Q9NZH0)](https://www.uniprot.org/uniprot/Q9NZH0)
- [GeneCards: GPR39](https://www.genecards.org/cgi-bin/carddisp.pl?gene=GPR39)
- [PubMed: GPR39 zinc receptor](https://pubmed.ncbi.nlm.nih.gov/search/?term=GPR39+zinc+receptor+brain)
Background
The study of Gpr39 Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Brain Atlas Resources
- [Allen Brain Cell Atlas](https://portal.brain-map.org/atlases-and-data/bkp/abc-atlas) - Cell type taxonomy
- [Allen Cell Type Atlas](https://celltypes.brain-map.org/) - Single-cell expression data
- [Allen Mouse Brain Atlas](https://mouse.brain-map.org/) - Mouse brain reference data
- [Allen Human Brain Atlas](https://human.brain-map.org/microarray) - Gene expression data
See Also
- [AKT1 Protein (Protein Kinase B Alpha)](/wiki/proteins-akt1) — activates
- [AMPK Agonist Therapy for Neurodegeneration](/wiki/ideas-payload-ampk-agonist-neurodegeneration) — activates
- [AMPK Agonist Therapy for Neurodegeneration](/wiki/ideas-payload-ampk-agonist-neurodegeneration) — modulates
- [CaMKII Protein (CaMK2A)](/wiki/proteins-camk2a) — activates
Pathway Diagram
The following diagram shows the key molecular relationships involving GPR39 Neurons discovered through SciDEX knowledge graph analysis:
Mermaid diagram (expand to render)